EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 (Mars 2013) Hors série n°1 Med Sci (Paris), 29 (2013) 13-18 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Mars 2013
Mucormycoses
Page(s) 13 - 18
Section M/S Revues
DOI https://doi.org/10.1051/medsci/201329s104
Published online 13 March 2013
  1. Lanternier F, Dannaoui E, Morizot, G, et al. A global analysis of mucormycosis in France: the Retrozygo study (2005–2007). Clin Infect Dis 2012 ; 54 : (suppl 1) : S35–S43. [CrossRef] [PubMed] [Google Scholar]
  2. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005 ; 41 : 634–653. [CrossRef] [PubMed] [Google Scholar]
  3. Singh N, Aguado JM, Bonatti H, et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis 2009 ; 200 : 1002–1011. [CrossRef] [PubMed] [Google Scholar]
  4. Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011 ; 17 : 1859–1867. [CrossRef] [PubMed] [Google Scholar]
  5. Lanternier F, Sun HY, Ribaud P, et al. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis 2012 ; 54 : 1629–1636. [CrossRef] [PubMed] [Google Scholar]
  6. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994 ; 19 : 67–76. [CrossRef] [PubMed] [Google Scholar]
  7. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (Transnet) Database. Clin Infect Dis 2010 ; 50 : 1091–1100. [CrossRef] [PubMed] [Google Scholar]
  8. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 2009 ; 15 : 1395–1401. [CrossRef] [PubMed] [Google Scholar]
  9. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000 ; 13 : 236–301. [CrossRef] [PubMed] [Google Scholar]
  10. Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis 2012 ; 54 (suppl 1) : S44–S54. [CrossRef] [PubMed] [Google Scholar]
  11. Voigt K, Cigelnik E, O’Donnell K. Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data. J Clin Microbiol 1999 ; 37 : 3957–3964. [PubMed] [Google Scholar]
  12. Voigt K, Wostemeyer J. Phylogeny and origin of 82 zygomycetes from all 54 genera of the Mucorales and Mortierellales based on combined analysis of actin and translation elongation factor EF-1alpha genes. Gene 2001 ; 270 : 113–120. [CrossRef] [PubMed] [Google Scholar]
  13. O’Donnell K, Lutzoni F, Ward TJ, Benny GL. Evolutionary relationships among mucoralean fungi (Zygomycota): evidence for family polyphyly on a large scale. Mycologia 2001 ; 93 : 286–296. [CrossRef] [Google Scholar]
  14. Hibbett DS, Binder M, Bischoff JF, et al. A higher-level phylogenetic classification of the Fungi. Mycol Res 2007 ; 111 : 509–547. [CrossRef] [PubMed] [Google Scholar]
  15. Ruping MJ, Heinz WJ, Kindo AJ, et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 2010 ; 65 : 296–302. [CrossRef] [PubMed] [Google Scholar]
  16. Alvarez E, Sutton DA, Cano J, et al. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol 2009 ; 47 : 1650–1656. [CrossRef] [PubMed] [Google Scholar]
  17. Garcia-Hermoso D, Dannaoui E, Lortholary O, Dromer F. Agents of systemic and subcutaneous mucormycosis and entomophthoromycosis. In : Manual of clinical microbiology. Washington DC : American Society for Microbiology, 2011. [Google Scholar]
  18. Haurany N, Kontoyiannis DP, Buchanan M, et al. Interobserver reproducibility and concordance between culture and histopathology in invasive mold infections: a multicenter study. In : 4th Advances against Aspergillosis. Rome, Italy, 2010 (abstract 78). [Google Scholar]
  19. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008 ; 46 : 1813–1821. [CrossRef] [PubMed] [Google Scholar]
  20. Ayats J, Martin-Mazuelos E, Peman J, et al. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update. Enferm Infect Microbiol Clin 2011 ; 29 : 39e31–15. [CrossRef] [Google Scholar]
  21. Walsh TJ, Gamaletsou MN, McGinnis MR, et al. Early clinical, laboratory diagnosis of invasive pulmonary, extrapulmonary, disseminated mucormycosis (zygomycosis). Clin Infect Dis 2012 ; 54 (suppl 1) : S55–S60. [CrossRef] [PubMed] [Google Scholar]
  22. Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med 2001 ; 125 : 375–378. [PubMed] [Google Scholar]
  23. Hammond SP, Bialek R, Milner DA, et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol 2011 ; 49 : 2151–2153. [CrossRef] [PubMed] [Google Scholar]
  24. Hayden RT, Qian X, Procop GW, et al. In situ hybridization for the identification of filamentous fungi in tissue section. Diagn Mol Pathol 2002 ; 11 : 119–126. [CrossRef] [PubMed] [Google Scholar]
  25. Montone KT, LiVolsi VA, Lanza DC, et al. In situ hybridization for specific fungal organisms in acute invasive fungal rhinosinusitis. Am J Clin Pathol 2011 ; 135 : 190–199. [CrossRef] [PubMed] [Google Scholar]
  26. Schwarz P, Lortholary O, Dromer F, Dannaoui E. Carbon assimilation profiles as a tool for identification of zygomycetes. J Clin Microbiol 2007 ; 45 : 1433–1439. [CrossRef] [PubMed] [Google Scholar]
  27. Kontoyiannis DP, Chamilos G, Hassan SA, et al. Increased culture recovery of Zygomycetes under physiologic temperature conditions. Am J Clin Pathol 2007 ; 127 : 208–212. [CrossRef] [PubMed] [Google Scholar]
  28. Alvarez E, Garcia-Hermoso D, Sutton DA, et al. Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol 2010 ; 48 : 4410–4416. [CrossRef] [PubMed] [Google Scholar]
  29. De Hoog GS, Guarro J, Gené J, Figueras MJ., Atlas of clinical fungi CD-ROM. A pilot CD-ROM version of the 3rd ed. Utrecht, The Netherlands : Centraalbureau voor Schimmelcultures, 2009. [Google Scholar]
  30. Ellis D, Davis S, Alexiou H, et al. Descriptions of medical fungi. Adelaide, Australia, 2007. [Google Scholar]
  31. Schoch CL, Seifert KA, Huhndorf S, et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci USA 2012 ; 109 : 6241–6246. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.